Short Interest in Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Decreases By 16.7%

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRFGet Rating) (TSE:CPH) saw a significant drop in short interest in July. As of July 15th, there was short interest totalling 500 shares, a drop of 16.7% from the June 30th total of 600 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is currently 0.2 days.

Cipher Pharmaceuticals Trading Down 2.9 %

Shares of CPHRF stock opened at $1.70 on Thursday. The stock has a 50 day moving average of $1.75 and a 200 day moving average of $1.73. Cipher Pharmaceuticals has a twelve month low of $1.06 and a twelve month high of $2.25.

Cipher Pharmaceuticals Company Profile

(Get Rating)

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.